Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection
- PMID: 17133491
- DOI: 10.1002/hep.21438
Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection
Abstract
CD8 T cell killing of hepatitis C virus (HCV)-infected hepatocytes is thought to contribute to liver damage during chronic HCV infection, whereas the participation of HCV-nonspecific immune cells is unclear. To visualize the spatial relationship of HCV-specific CD8 T cells with parenchymal target cells, and to examine their local functional activity in relation to hepatocellular necrosis and fibrosis, we used HLA tetramers and confocal microscopy in biopsies from 23 HLA-A2 or HLA-B7 patients with chronic HCV infection. Intrahepatic tetramer+ (HCV-specific) CD8 T cells protected from hepatic necroinflammatory disease activity, independently of age, gender, viral load, and viral genotype. Indeed, tetramer+ cells were scattered in the liver within regions of weak fibrosis (low laminin expression) and low hepatocellular apoptosis (TUNEL method), and expressed IL-10 but not IFNgamma. By contrast, tetramer-negative CD8 T cells were associated with active necroinflammatory liver disease, colocalized with strong laminin expression and hepatocellular apoptosis, and expressed more frequently IFNgamma than IL-10. Overall, liver regions harboring HCV-specific CD8 T cells tended to be healthier than areas containing only inflammatory cells of undefined specificity. In conclusion, HCV-specific IL-10-producing CD8 T cells, although not cytotoxic and unable to control viral replication, can attenuate hepatocellular necrosis, liver fibrosis, and inflammation mediated by bystander T cells, and may thus represent antigen-induced regulatory CD8 T cells. Therapeutic modulation of the intrahepatic balance between specific and bystander CD8 T cells might be beneficial in patients with chronic hepatitis C.
Similar articles
-
Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.Hepatology. 2005 Oct;42(4):828-37. doi: 10.1002/hep.20856. Hepatology. 2005. PMID: 16175596
-
Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.J Med Virol. 2004 Apr;72(4):575-85. doi: 10.1002/jmv.20036. J Med Virol. 2004. PMID: 14981760
-
Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.J Viral Hepat. 2006 Jul;13(7):474-81. doi: 10.1111/j.1365-2893.2005.00711.x. J Viral Hepat. 2006. PMID: 16792541
-
Chronic hepatitis C in the advanced adult and elderly subjects.Minerva Gastroenterol Dietol. 2009 Jun;55(2):145-57. Minerva Gastroenterol Dietol. 2009. PMID: 19305374 Review.
-
Pathophysiology of hepatitis C virus infection and related liver disease.Trends Microbiol. 2004 Feb;12(2):96-102. doi: 10.1016/j.tim.2003.12.005. Trends Microbiol. 2004. PMID: 15036326 Review.
Cited by
-
Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?Front Immunol. 2012 Nov 26;3:351. doi: 10.3389/fimmu.2012.00351. eCollection 2012. Front Immunol. 2012. PMID: 23420385 Free PMC article.
-
CD8 T cell exhaustion in human visceral leishmaniasis.J Infect Dis. 2014 Jan 15;209(2):290-9. doi: 10.1093/infdis/jit401. Epub 2013 Aug 6. J Infect Dis. 2014. PMID: 23922369 Free PMC article.
-
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy.Arch Immunol Ther Exp (Warsz). 2019 Apr;67(2):79-88. doi: 10.1007/s00005-018-0532-8. Epub 2018 Nov 15. Arch Immunol Ther Exp (Warsz). 2019. PMID: 30443787 Free PMC article. Review.
-
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.J Clin Invest. 2009 Jul;119(7):1745-54. doi: 10.1172/JCI39133. Epub 2009 Jul 1. J Clin Invest. 2009. PMID: 19587449 Free PMC article. Review.
-
Enhanced liver regeneration in IL-10-deficient mice after partial hepatectomy via stimulating inflammatory response and activating hepatocyte STAT3.Am J Pathol. 2011 Apr;178(4):1614-21. doi: 10.1016/j.ajpath.2011.01.001. Am J Pathol. 2011. PMID: 21435447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous